Clinical Trial Update: Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on treatment of high-risk cerebral primitive neuroectodermal tumors in children over 5 years old.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Primitive Neuroectodermal Tumor

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Metastatic, Cerebral Primitive Neuroectodermal Tumors | Phase 2 | Status: COMPLETED